Stockreport

OKYO Pharma to Participate at the 4th Annual BTIG Ophthalmology Conference [Yahoo! Finance]

OKYO Pharma Limited - American Depositary Shares  (OKYO) 
PDF innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an FDA approved therapy, and for inflammatory dry eye disease [Read more]